These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26515338)

  • 1. Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation.
    Attar-Schneider O; Zismanov V; Drucker L; Gottfried M
    Tumour Biol; 2016 Apr; 37(4):4755-65. PubMed ID: 26515338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Niche origin of mesenchymal stem cells derived microvesicles determines opposing effects on NSCLC: Primary versus metastatic.
    Attar-Schneider O; Dabbah M; Drucker L; Gottfried M
    Cell Signal; 2020 Jan; 65():109456. PubMed ID: 31672605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of mesenchymal stem cells' secretome on lung cancer progression is contingent on their origin: primary or metastatic niche.
    Attar-Schneider O; Drucker L; Gottfried M
    Lab Invest; 2018 Dec; 98(12):1549-1561. PubMed ID: 30089856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation.
    Marcus H; Attar-Schneider O; Dabbah M; Zismanov V; Tartakover-Matalon S; Lishner M; Drucker L
    Cell Signal; 2016 Jun; 28(6):620-30. PubMed ID: 26976208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.
    Attar-Schneider O; Zismanov V; Dabbah M; Tartakover-Matalon S; Drucker L; Lishner M
    Mol Carcinog; 2016 Sep; 55(9):1343-54. PubMed ID: 26293751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
    Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
    J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect and molecular mechanism of mesenchymal stem cells on NSCLC cells.
    Pan M; Hou L; Zhang J; Zhao D; Hua J; Wang Z; He J; Jiang H; Hu H; Zhang L
    Mol Cell Biochem; 2018 Apr; 441(1-2):63-76. PubMed ID: 28887716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migration and epithelial-to-mesenchymal transition of lung cancer can be targeted via translation initiation factors eIF4E and eIF4GI.
    Attar-Schneider O; Drucker L; Gottfried M
    Lab Invest; 2016 Sep; 96(9):1004-15. PubMed ID: 27501049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.
    Ibraheem A; Attar-Schneider O; Dabbah M; Dolberg Jarchowsky O; Tartakover Matalon S; Lishner M; Drucker L
    Transl Res; 2019 May; 207():83-95. PubMed ID: 30738861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of bone marrow mesenchymal stem cell secretome by ECM-like hydrogels.
    Silva NA; Moreira J; Ribeiro-Samy S; Gomes ED; Tam RY; Shoichet MS; Reis RL; Sousa N; Salgado AJ
    Biochimie; 2013 Dec; 95(12):2314-9. PubMed ID: 23994751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication.
    Dabbah M; Lishner M; Jarchowsky-Dolberg O; Tartakover-Matalon S; Brin YS; Pasmanik-Chor M; Neumann A; Drucker L
    Transl Res; 2021 Oct; 236():117-132. PubMed ID: 33887527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.
    Dabbah M; Attar-Schneider O; Tartakover Matalon S; Shefler I; Jarchwsky Dolberg O; Lishner M; Drucker L
    Carcinogenesis; 2017 Jul; 38(7):708-716. PubMed ID: 28838065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
    Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
    J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling.
    Attar-Schneider O; Pasmanik-Chor M; Tartakover-Matalon S; Drucker L; Lishner M
    Oncotarget; 2015 Feb; 6(6):4315-29. PubMed ID: 25717031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLC.
    Cao Y; Wei M; Li B; Liu Y; Lu Y; Tang Z; Lu T; Yin Y; Qin Z; Xu Z
    Oncotarget; 2016 Apr; 7(17):24242-51. PubMed ID: 27003362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigational Study of Mesenchymal Stem Cells on Lung Cancer Cell Proliferation and Invasion].
    Li M; Wu Y; Liu R; Guo L; Xu T; Chen J; Xu S
    Zhongguo Fei Ai Za Zhi; 2015 Nov; 18(11):674-9. PubMed ID: 26582222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.
    Fontanella R; Pelagalli A; Nardelli A; D'Alterio C; Ieranò C; Cerchia L; Lucarelli E; Scala S; Zannetti A
    Cancer Lett; 2016 Jan; 370(1):100-7. PubMed ID: 26517945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
    Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
    Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
    Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
    J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells in non-small cell lung cancer--different from others? Insights from comparative molecular and functional analyses.
    Gottschling S; Granzow M; Kuner R; Jauch A; Herpel E; Xu EC; Muley T; Schnabel PA; Herth FJ; Meister M
    Lung Cancer; 2013 Apr; 80(1):19-29. PubMed ID: 23294501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.